Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples.

Virchows Archiv : an international journal of pathology - 1 Oct 2018

Williams Hannah L, Walsh Kathy, Diamond Austin, Oniscu Anca, Deans Zandra C

Abstract excerpt

The clinical utility of next-generation sequencing (NGS) for a diverse range of targets is expanding, increasing the need for multiplexed analysis of both DNA and RNA. However, translation into daily use requires a rigorous and comprehensive validation strategy. The aim of this clinical validation was to assess the performance of the Ion Torrent Personal Genome Machine (IonPGM™) and validate the Oncomine™ Focus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Fusion

Share to Molecular Diagnostic Techniques

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Reproducibility of Results

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 30105577
DOI: 10.1007/s00428-018-2411-4
PMCID: PMC6182325

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples.PMID 30105577Read ↗

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.Semantic proximity Read ↗

Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory.Semantic proximity Read ↗

Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.Semantic proximity Read ↗

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.Semantic proximity Read ↗

Use of the Ion AmpliSeq Cancer Hotspot Panel in clinical molecular pathology laboratories for analysis of solid tumours: With emphasis on validation with relevant single molecular pathology tests and the Oncomine Focus Assay.Semantic proximity Read ↗

Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratorySemantic proximity Read ↗

Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.Semantic proximity Read ↗

Clinical validation of the tempus xT next-generation targeted oncology sequencing assaySemantic proximity Read ↗

Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.Semantic proximity Read ↗

Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid TumorsSemantic proximity Read ↗

Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.Semantic proximity Read ↗

Validation of a Customized Bioinformatics Pipeline for a Clinical Next-Generation Sequencing Test Targeting Solid Tumor-Associated Variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.